Condition 1: Stress urinary incontinence. Condition 2: Mixed urinary incontinence. Stress incontinence -
Conditions
Interventions
Intervention time is 6 weeks
Intervention 1: Intervention group: Saussurea costus oil
local use
frequency of use of the drug twice a day
Area of oil application is navel to pubic area
Each time the oil volume is 2/3 ml
Intervention time is 6 weeks. Intervention 2: control group: placebo oil
Frequency of use of the drug twice a day
Each time the volume of oil is 2/3 ml
Intervention time is 6 weeks.
Treatment - Drugs
Intervention group: Saussurea costus oil
Sponsors
Vice Chancellor for research, School of Traditional medicine, Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 30-70 old women with stress or mixed urinary incontinence; Being symptomatic for at least 3 months; not been treated for at least 2 week before study; Who are willing to participate in research and Have signed a consent form; After explaining the research objectives of the study and informed consent, patients will be enrolled. Exclusion criteria: acute or recurrent urinary tract infection; pregnancy or lack of contraception; allergy to oily drug products; chronic degenerative neuromuscular disease; Bladder cancer or previous record of it; pain of bladder or painful urine voiding; disease or drugs that were be effective on our research results such as diuretics; record of pelvic surgery during past one year; drug misuse during study; Unwillingness to continue participation in the study; drug side effects during study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency of urinary leakage. Timepoint: At the beginning of the intervention, after 3 and 6 weeks, 1 month after end of intervention. Method of measurement: International Consultation on Incontinence Questionnaire -Urinary Incontinence Short Form (ICIQ-SF) questionnaire.;The amount of urine leakage. Timepoint: At the beginning of the intervention, after 3 and 6 weeks, 1 month after end of intervention. Method of measurement: International Consultation on Incontinence Questionnaire -Urinary Incontinence Short Form (ICIQ-SF) questionnaire.;Time leakage: leakage befor sleep. Timepoint: At the beginning of the intervention, after 3 and 6 weeks, 1 month after end of intervention. Method of measurement: International Consultation on Incontinence Questionnaire -Urinary Incontinence Short Form (ICIQ-SF) questionnaire.;Time of leakage: leakage before reaching the bathroom. Timepoint: At the beginning of the intervention, after 3 and 6 weeks, 1 month after end of intervention. Method of measurement: International Consultation on Incontinence Questionnaire -Urinary Incontinence Short Form (ICIQ-SF) questionnaire.;Time leakage: leakage of urine with coughing and sneezing. Timepoint: At the beginning of the intervention, after 3 and 6 weeks, 1 month after end of intervention. Method of measurement: International Consultation on Incontinence Questionnaire -Urinary Incontinence Short Form (ICIQ-SF) questionnaire.;The leakage of urine: leakage of urine with exercise. Timepoint: At the beginning of the intervention, after 3 and 6 weeks, 1 month after end of intervention. Method of measurement: International Consultation on Incontinence Questionnaire -Urinary Incontinence Short Form (ICIQ-SF) questionnaire.;The leakage of urine: urine leakage after urination immediately prior to wearing underwear. Timepoint: At the beginning of the intervention, after 3 and 6 weeks, 1 month after end of intervention. Method of measurement: International Consultation on Incontinence Questionnaire -U | — |
Secondary
| Measure | Time frame |
|---|---|
| Presumptive skin complications. Timepoint: 3 weeks after research start and 6 weeks after that (end of intervention). Method of measurement: Measurement form of drug complications According to Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Niktabe
School of Traditional Medicine, Tehran University of Medical Sciences, Iran
Outcome results
None listed